Special Notice NAICS 621511

Q301 - ClonoSEQ Measurable Residual Disease (MRD) Testing Services

🏢 VETERANS AFFAIRS, DEPARTMENT OF 📅 Posted 2025-11-04 ⏳ Due 2025-11-12T20:00:00+00:00
Notice of Intent to Sole-Source Requirement: The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 621511, Size Standard is $41.5 Million. The Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: ADAPTIVE BIOTECHNOLOGIES CORPORATION UEI: DMW5BNQ331K9 Description of requirements: The VA Northeast Ohio Healthcare System (VANEOHS), Pathology and Laboratory Medicine Service (PALMS), requires molecular minimal residual disease (MRD) testing services utilizing the clonoSEQ Assay provided exclusively by Adaptive Biotechnologies. The clonoSEQ Assay is a proprietary, patented molecular test developed and performed exclusively by Adaptive Biotechnologies. Adaptive Biotechnologies is the sole source provider of clonoSEQ MRD testing within the United States. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is ...

Notice ID: e20d8f5c834840859e63658c02d4d6f5 · View on SAM.gov ↗

Explore more federal-contracting data

Browse opportunities by NAICS code · set-aside category · state & jurisdiction · buying agency

Win more federal contracts

BidChamp gives small businesses AI-powered bid writing, document analysis, and recompete forecasting - for free during your trial.

Sign up free - 14-day trial, no card required